Zacks: Brokerages Anticipate La Jolla Pharmaceutical (LJPC) Will Post ...


Wall Street analysts expect La Jolla Pharmaceutical to report sales of $3.38 million for the current quarter, according to Zacks Investment Research . Four analysts have provided estimates for La Jolla Pharmaceutical's earnings.



from Biotech News